This product is a fourth-generation quinolone antibacterial drug. Its mechanism of action is a DNA topoisomerase inhibitor, which prevents bacterial DNA from forming a supercoiled structure, causing bacterial cells to be unable to divide and proliferate and die.

It is a nutritional medicine that can supplement calories and improve sugar metabolism. Its metabolism in the body does not rely on the participation of insulin. It directly participates in sugar metabolism through the cell membrane without increasing blood sugar concentration. Its sweetness and heat generation are similar to those of glucose. It can be used as a sugar substitute for diabetic patients. In addition, it has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids. It can be used as a combined drug for diabetes and ketoacidosis during surgical anesthesia.

It is a nutritional medicine that can supplement calories and improve sugar metabolism. Its metabolism in the body does not rely on the participation of insulin. It directly participates in sugar metabolism through the cell membrane without increasing blood sugar concentration. Its sweetness and heat generation are similar to those of glucose. It can be used as a sugar substitute for diabetic patients. In addition, it has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids. It can be used as a combined drug for diabetes and ketoacidosis during surgical anesthesia.

It is a nutritional medicine that can supplement calories and improve sugar metabolism. Its metabolism in the body does not rely on the participation of insulin. It directly participates in sugar metabolism through the cell membrane without increasing blood sugar concentration. Its sweetness and heat generation are similar to those of glucose. It can be used as a sugar substitute for diabetic patients. In addition, it has the effect of inhibiting the production of ketone bodies and can reduce the production of plasma fatty acids. It can be used as a combined drug for diabetes and ketoacidosis during surgical anesthesia.

This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill the bacteria.